Lack of mutations within ST7 gene in tumour-derived cell lines and primary epithelial tumours
2002

Study of ST7 Gene Mutations in Tumors

Sample size: 94 publication Evidence: moderate

Author Information

Author(s): Brown V L, Proby C M, Barnes D M, Kelsell D P

Primary Institution: Centre for Cutaneous Research, Barts and The London, Queen Mary's School of Medicine and Dentistry

Hypothesis

Is the ST7 gene mutated in various epithelial tumors and cancer cell lines?

Conclusion

The study found that mutations in the ST7 gene are very rare in epithelial cancers and tumor cell lines.

Supporting Evidence

  • Only one missense mutation was detected in a breast cancer cell line.
  • Previous studies reported more mutations, but this study found none in the examined samples.
  • High rates of loss of heterozygosity were observed in breast tumors.
  • Mutations were not found in other cancer types examined.

Takeaway

The ST7 gene, which might help prevent cancer, doesn't have many mutations in tumors, suggesting other factors might be more important.

Methodology

Mutational analysis of ST7 exons was performed using denaturing high performance liquid chromatography (DHPLC) on various cancerous and non-cancerous cell lines and primary epithelial cancer tissues.

Limitations

The study may not have detected all possible mutations due to the specific exons analyzed.

Participant Demographics

Included 34 primary breast cancers, 27 sporadic cutaneous squamous cell carcinomas, 34 cancer-derived cell lines, and 27 non-cancerous cell lines.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6600418

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication